The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Freezing of Gait Treatment Market Research Report 2025
Synopsis
Freezing of gait, or FOG, is said to affect approximately 7% of individuals with early Parkinson’s disease (PD) and more than half of those with advanced PD.1This is due to the loss of postural reflexes, which are automatic movements that help us maintain equilibrium and balance when we are standing upright. FOG is usually defined as an onset of not being able to start stepping forward, with no apparent cause, and can be exacerbated by stress or distraction.1 FOG can look like trembling of the legs, shortening of steps or shuffling, or feeling like one is unable to move their feet.2 It’s one of the most debilitating aspects of PD and can increase fall risk. While there is no known cure for this, there are potential treatments for it, and ways to prevent FOG are being explored.
The global Freezing of Gait Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Freezing of Gait Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Freezing of Gait Treatment.
Report Scope
The Freezing of Gait Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Freezing of Gait Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Freezing of Gait Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acorda Therapeutics
The Michael J. Fox Foundation
GYENNO
MedEXO Robotics
TABLE Teva Pharmaceuticals
Segment by Type
Oral Dopaminergic Medication
Wearable and Walking Aid Devices
Deep Brain Stimulation
Others
Segment by Application
Hospitals
Clinics
Research and Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Freezing of Gait Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Freezing of gait, or FOG, is said to affect approximately 7% of individuals with early Parkinson’s disease (PD) and more than half of those with advanced PD.1This is due to the loss of postural reflexes, which are automatic movements that help us maintain equilibrium and balance when we are standing upright. FOG is usually defined as an onset of not being able to start stepping forward, with no apparent cause, and can be exacerbated by stress or distraction.1 FOG can look like trembling of the legs, shortening of steps or shuffling, or feeling like one is unable to move their feet.2 It’s one of the most debilitating aspects of PD and can increase fall risk. While there is no known cure for this, there are potential treatments for it, and ways to prevent FOG are being explored.
The global Freezing of Gait Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Freezing of Gait Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Freezing of Gait Treatment.
Report Scope
The Freezing of Gait Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Freezing of Gait Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Freezing of Gait Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Acorda Therapeutics
The Michael J. Fox Foundation
GYENNO
MedEXO Robotics
TABLE Teva Pharmaceuticals
Segment by Type
Oral Dopaminergic Medication
Wearable and Walking Aid Devices
Deep Brain Stimulation
Others
Segment by Application
Hospitals
Clinics
Research and Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Freezing of Gait Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Freezing of Gait Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Dopaminergic Medication
1.2.3 Wearable and Walking Aid Devices
1.2.4 Deep Brain Stimulation
1.2.5 Others
1.3 Market by Application
1.3.1 Global Freezing of Gait Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research and Academic Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Freezing of Gait Treatment Market Perspective (2019-2030)
2.2 Freezing of Gait Treatment Growth Trends by Region
2.2.1 Global Freezing of Gait Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Freezing of Gait Treatment Historic Market Size by Region (2019-2024)
2.2.3 Freezing of Gait Treatment Forecasted Market Size by Region (2025-2030)
2.3 Freezing of Gait Treatment Market Dynamics
2.3.1 Freezing of Gait Treatment Industry Trends
2.3.2 Freezing of Gait Treatment Market Drivers
2.3.3 Freezing of Gait Treatment Market Challenges
2.3.4 Freezing of Gait Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Freezing of Gait Treatment Players by Revenue
3.1.1 Global Top Freezing of Gait Treatment Players by Revenue (2019-2024)
3.1.2 Global Freezing of Gait Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Freezing of Gait Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Freezing of Gait Treatment Revenue
3.4 Global Freezing of Gait Treatment Market Concentration Ratio
3.4.1 Global Freezing of Gait Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Freezing of Gait Treatment Revenue in 2023
3.5 Freezing of Gait Treatment Key Players Head office and Area Served
3.6 Key Players Freezing of Gait Treatment Product Solution and Service
3.7 Date of Enter into Freezing of Gait Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Freezing of Gait Treatment Breakdown Data by Type
4.1 Global Freezing of Gait Treatment Historic Market Size by Type (2019-2024)
4.2 Global Freezing of Gait Treatment Forecasted Market Size by Type (2025-2030)
5 Freezing of Gait Treatment Breakdown Data by Application
5.1 Global Freezing of Gait Treatment Historic Market Size by Application (2019-2024)
5.2 Global Freezing of Gait Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Freezing of Gait Treatment Market Size (2019-2030)
6.2 North America Freezing of Gait Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Freezing of Gait Treatment Market Size by Country (2019-2024)
6.4 North America Freezing of Gait Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Freezing of Gait Treatment Market Size (2019-2030)
7.2 Europe Freezing of Gait Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Freezing of Gait Treatment Market Size by Country (2019-2024)
7.4 Europe Freezing of Gait Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Freezing of Gait Treatment Market Size (2019-2030)
8.2 Asia-Pacific Freezing of Gait Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Freezing of Gait Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Freezing of Gait Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Freezing of Gait Treatment Market Size (2019-2030)
9.2 Latin America Freezing of Gait Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Freezing of Gait Treatment Market Size by Country (2019-2024)
9.4 Latin America Freezing of Gait Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Freezing of Gait Treatment Market Size (2019-2030)
10.2 Middle East & Africa Freezing of Gait Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Freezing of Gait Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Freezing of Gait Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acorda Therapeutics
11.1.1 Acorda Therapeutics Company Detail
11.1.2 Acorda Therapeutics Business Overview
11.1.3 Acorda Therapeutics Freezing of Gait Treatment Introduction
11.1.4 Acorda Therapeutics Revenue in Freezing of Gait Treatment Business (2019-2024)
11.1.5 Acorda Therapeutics Recent Development
11.2 The Michael J. Fox Foundation
11.2.1 The Michael J. Fox Foundation Company Detail
11.2.2 The Michael J. Fox Foundation Business Overview
11.2.3 The Michael J. Fox Foundation Freezing of Gait Treatment Introduction
11.2.4 The Michael J. Fox Foundation Revenue in Freezing of Gait Treatment Business (2019-2024)
11.2.5 The Michael J. Fox Foundation Recent Development
11.3 GYENNO
11.3.1 GYENNO Company Detail
11.3.2 GYENNO Business Overview
11.3.3 GYENNO Freezing of Gait Treatment Introduction
11.3.4 GYENNO Revenue in Freezing of Gait Treatment Business (2019-2024)
11.3.5 GYENNO Recent Development
11.4 MedEXO Robotics
11.4.1 MedEXO Robotics Company Detail
11.4.2 MedEXO Robotics Business Overview
11.4.3 MedEXO Robotics Freezing of Gait Treatment Introduction
11.4.4 MedEXO Robotics Revenue in Freezing of Gait Treatment Business (2019-2024)
11.4.5 MedEXO Robotics Recent Development
11.5 TABLE Teva Pharmaceuticals
11.5.1 TABLE Teva Pharmaceuticals Company Detail
11.5.2 TABLE Teva Pharmaceuticals Business Overview
11.5.3 TABLE Teva Pharmaceuticals Freezing of Gait Treatment Introduction
11.5.4 TABLE Teva Pharmaceuticals Revenue in Freezing of Gait Treatment Business (2019-2024)
11.5.5 TABLE Teva Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
